RCM Technologies, Inc. — Form 10-Q Summary
Period clarification: Request metadata identifies 2014 Q3, but the filing is for the 13- and 39-week periods ended October 3, 2015, compared with periods ended September 27, 2014. The 10-Q was signed November 5, 2015.
Business context and reporting period
RCM provides engineering, information technology, and specialty health-care staffing and consulting services. The company reports on a 52/53-week fiscal calendar. Results below are unaudited; amounts are in U.S. dollars.
Financial performance and liquidity
| Metric | 13 weeks ended Oct. 3, 2015 | 13 weeks ended Sept. 27, 2014 | 39 weeks ended Oct. 3, 2015 | 39 weeks ended Sept. 27, 2014 |
|---|---|---|---|---|
| Revenue | $45.1M | $46.4M | $138.3M | $144.5M |
| Gross profit / margin | $12.8M / 28.4% | $13.2M / 28.4% | $38.2M / 27.6% | $38.4M / 26.6% |
| Operating income / margin | $1.9M / 4.2% | $2.8M / 6.1% | $5.5M / 4.0% | $7.9M / 5.5% |
| Net income | $1.0M | $1.9M | $3.0M | $5.1M |
| Diluted EPS | $0.07 | $0.15 | $0.23 | $0.40 |
- For the 39-week period, operating cash flow was $7.5M, versus $1.2M a year earlier; investing cash use was $3.3M and financing cash use was $5.2M. Cash declined $1.9M to $4.5M.
- At October 3, 2015, total assets were $81.7M, total liabilities $37.6M, and stockholders’ equity $44.1M. Cash was $4.5M; borrowings under the revolving credit facility were $15.0M, down from $20.0M at January 3, 2015.
- The $35M revolving facility matures December 11, 2019; $19.2M was available for additional borrowing, net of outstanding letters of credit. The effective rate, including unused-line fees, was 2.5%. RCM reported compliance with all covenants.
Material changes versus comparable periods
- Year-to-date revenue fell 4.2%, while operating income declined 30.7% and net income declined 40.4%. Gross margin improved to 27.6% from 26.6%, but higher SG&A and depreciation costs reduced operating margin.
- Engineering was the primary headwind: 39-week revenue fell 18.2% to $61.8M and operating income fell to $2.2M from $5.3M. Reduced Canadian project activity and the weaker Canadian dollar contributed; management estimated the currency effect reduced year-to-date revenue by $3.5M.
- Information Technology revenue rose 1.3% to $44.7M; Specialty Health Care revenue increased 28.4% to $31.8M, with operating income rising to $1.0M from $0.1M. Growth in newer health-care service lines and offices contributed.
- Year-to-date SG&A rose 6.9% to $31.6M, including increased selling, recruiting, compensation, medical claims, equity compensation, and IT infrastructure costs. Interest expense also increased, primarily due to facility borrowing used to finance a $25.3M special dividend in fiscal 2014.
Outlook, risks, and unusual items
- No specific revenue or earnings guidance is provided. Management describes demand as sensitive to economic conditions and customer spending, and identifies competition, pricing pressure, hiring and retention, customer concentration, acquisitions, and Canadian-dollar movements as risks.
- Management said available capital resources should cover obligations in the normal course for at least 12 months. Planned spending includes up to $1.0M for the first phase of a project-management platform, potentially another $0.5M for expansion, and an estimated $1.0M–$2.0M to upgrade or replace the SAP financial system, possibly beginning in fiscal 2016.
- A dispute involving Black & McDonald and Ontario Power Generation affects $1.7M of RCM’s disputed receivables; total receivables from B&M were $5.8M. RCM believes the receivables remain collectible, subject to existing reserves, but acknowledges collection could be delayed. The filing reports no accrual for legal liabilities; asserted claims in other matters totaled approximately $1.9M.
- Estimated future acquisition contingent consideration was $1.9M. Estimates depend on forecast performance and may differ materially from actual payments. The SDS acquisition added $0.8M of cash payments, $1.4M of goodwill, and $0.1M of intangible assets.
- Foreign-currency translation reduced comprehensive income by $2.6M over 39 weeks. RCM reported no derivatives to hedge foreign-exchange or interest-rate exposure; a 1 percentage-point increase in the variable borrowing rate would have increased period interest expense by an estimated $0.2M.
- The company reported effective disclosure controls and no material changes to internal control over financial reporting during the quarter. It stated that risk factors had not materially changed from its prior annual report.
Important facts for investors to verify
- Confirm the period mismatch in the request metadata: this filing covers Q3 2015, not Q3 2014.
- Track Engineering demand and Canadian-dollar exposure, alongside whether Specialty Health Care growth translates into sustained operating profit.
- Monitor collection timing and reserves for the $5.8M B&M receivable balance and developments in the OPG dispute.
- Assess the effect of rising SG&A, planned systems spending, contingent acquisition payments, and the remaining revolving-credit balance on future cash generation.
- Review subsequent results against the company’s stated 12-month liquidity assessment; the filing provides no formal earnings guidance.